Your browser doesn't support javascript.
loading
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces.
Beca, J M; Dai, W F; Pataky, R E; Tran, D; Dvorani, E; Isaranuwatchai, W; Peacock, S; Alvi, R; Cheung, W Y; Earle, C C; Gavura, S; Chan, K K W.
Afiliación
  • Beca JM; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada. Electronic address: Jaclyn.beca@ontariohealth.ca.
  • Dai WF; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Pataky RE; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada; BC Cancer, Vancouver, British Columbia, Canada.
  • Tran D; Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada.
  • Dvorani E; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Isaranuwatchai W; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada; St. Michael's Hospital, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada.
  • Peacock S; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada; BC Cancer, Vancouver, British Columbia, Canada; Simon Fraser University, Burnaby, British Columbia, Canada.
  • Alvi R; Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada.
  • Cheung WY; Cancer Control Alberta, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Earle CC; Canadian Partnership Against Cancer, Toronto, Ontario, Canada; Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
  • Gavura S; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Chan KKW; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
Clin Oncol (R Coll Radiol) ; 34(1): e7-e17, 2022 01.
Article en En | MEDLINE | ID: mdl-34456106
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido